Arlene Chan

Paddles Up!: Dragon Boat Racing in Canada

Arlene Chan, Susan Humphries, 2009 .

Adjuvant trastuzumab in HER2-positive breast cancer.

Marc Buyse, Arlene Chan, Marek Pawlicki, 2011, The New England journal of medicine.

Accuracy of the oncology patients information system in a regional cancer centre.

Arlene Chan, Libni Eapen, Jonathan C Yau, 2002, Oncology reports.

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.

Arlene Chan, Andreas Schneeweiss, Luc Y Dirix, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC→T) with Doxorubicin and Cyclophosphamide Followed by Docetaxel and Trastuzumab (AC→TH) with Docetaxel, Carboplatin and Trastuzumab (TCH) in Her2neu Positive Early Breast Cancer Patients: BCIRG 006 Study.

John R. Mackey, Marc Buyse, Arlene Chan, 2009 .

Challenges to effective cancer control in China, India, and Russia.

Jun Wang, Shiying Yu, Arlene Chan, 2014, The Lancet. Oncology.